Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:43 PM ET Form 4
Insider Selling Medpace Holdings, Inc. MEDP

Medpace Holdings President & CEO August J. Troendle Sells $30.3M of Stock

August J. Troendle, President & CEO, sold 48,667 shares of Medpace Holdings, Inc. at $621.02 to $625.47 a share (average $623.03) in 2 transactions, worth $30.3M in total between Sep 29, 2026 and Sep 30, 2026. Shares held after the trade: 338,225 (-6.1%).

Value
$30.3M
Shares
48,667
Average price
$623.03
Role
President & CEO
Holding change
-6.1%
Trade date
Sep 29, 2026 to Sep 30, 2026
5:43 PM ET Form 4
Insider Buying Presurance Holdings, Inc. PRHI

Presurance Holdings Director James Grant Smith Buys $48.9K of Stock

James Grant Smith, Director, bought 7,250 shares of Presurance Holdings, Inc. at $6.75 a share, worth $48.9K in total on Sep 30, 2026. Shares held after the trade: 15,953 (+83.3%).

Value
$48.9K
Shares
7,250
Price
$6.75
Role
Director
Holding change
+83.3%
Trade date
Sep 30, 2026
5:43 PM ET Form 4
Insider Buying Oracle Corp ORCL

Oracle Insider Stephen H. Rusckowski Buys $3.48M of Stock

Stephen H. Rusckowski bought 25,000 shares of Oracle Corp at $139.35 a share, worth $3.48M in total on Sep 29, 2026. Shares held after the trade: 25,390 (+6410.3%).

Value
$3.48M
Shares
25,000
Price
$139.35
Holding change
+6410.3%
Trade date
Sep 29, 2026
5:40 PM ET Form 4
Insider Selling Gap Inc GAP

Gap Director William Sydney Fisher Sells $1.53M of Stock

William Sydney Fisher, Director, sold 66,344 shares of Gap Inc at $23.06 a share, worth $1.53M in total on Sep 30, 2026. Shares held after the trade: 16,336,854 (-0.4%).

Value
$1.53M
Shares
66,344
Price
$23.06
Role
Director
Holding change
-0.4%
Trade date
Sep 30, 2026
5:38 PM ET Form 4
Insider Buying Presurance Holdings, Inc. PRHI

Presurance Holdings CEO Brian J. Roney Buys $50.6K of Stock

Brian J. Roney, CEO, bought 7,500 shares of Presurance Holdings, Inc. at $6.75 a share, worth $50.6K in total on Sep 30, 2026. Shares held after the trade: 80,390 (+10.3%).

Value
$50.6K
Shares
7,500
Price
$6.75
Role
CEO
Holding change
+10.3%
Trade date
Sep 30, 2026
5:36 PM ET Form 4
Insider Selling Cracker Barrel Old Country Store, Inc CBRL

Cracker Barrel Old Country Store SVP, Chief HR Officer Donna Roberts Sells $182K of Stock

Donna Roberts, SVP, Chief HR Officer, sold 3,500 shares of Cracker Barrel Old Country Store, Inc at $52.08 a share, worth $182K in total on Oct 1, 2026. Shares held after the trade: 43,702 (-7.4%).

Value
$182K
Shares
3,500
Price
$52.08
Role
SVP, Chief HR Officer
Holding change
-7.4%
Trade date
Oct 1, 2026
5:33 PM ET Form 4
Insider Buying Presurance Holdings, Inc. PRHI

Presurance Holdings CFO, Treasurer Harold J. Meloche Buys $26.1K of Stock

Harold J. Meloche, CFO, Treasurer, bought 4,100 shares of Presurance Holdings, Inc. at $6.38 a share, worth $26.1K in total on Sep 30, 2026. Shares held after the trade: 14,468 (+39.5%).

Value
$26.1K
Shares
4,100
Price
$6.38
Role
CFO, Treasurer
Holding change
+39.5%
Trade date
Sep 30, 2026
5:31 PM ET 8-K
Business Update Forward Industries, Inc. FWDI

Forward Industries Business Update

Forward Industries provided a quarterly update on its Solana (SOL) treasury strategy, reporting that it increased its holdings by 948,601 SOL to a total of 8.5 million SOL as of September 30, 2026. The company reported that its SOL per share grew 10.4% during the quarter (42% annualized) and provided a preliminary net asset value (NAV) calculation of approximately $870.4 million.

Term
Q4 2026
5:30 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics EVP & General Counsel Paul A. Mahon Sells $4.69M of Stock

Paul A. Mahon, EVP & General Counsel, sold 8,300 shares of United Therapeutics Corp at $558.30 to $573.15 a share (average $564.95) in 10 transactions, worth $4.69M in total on Oct 1, 2026. Shares held after the trade: 45,332 (-1.8%).

Value
$4.69M
Shares
8,300
Average price
$564.95
Role
EVP & General Counsel
Holding change
-1.8%
Trade date
Oct 1, 2026
5:30 PM ET Form 4
Insider Buying Universal Safety Products, Inc. DCM

Universal Safety Products Director Milton C. Ault III Buys $92.4M of Stock

Milton C. Ault III, Director, bought 18,000 shares of Universal Safety Products, Inc. at $5,134.00 a share, worth $92.4M in total on Sep 30, 2026. Shares held after the trade: 1,166,096 (+1.6%).

Value
$92.4M
Shares
18,000
Price
$5,134.00
Role
Director
Holding change
+1.6%
Trade date
Sep 30, 2026
5:30 PM ET Form 4
Insider Buying PodcastOne, Inc. PODC

PodcastOne Insider D. Jonathan Merriman Buys $15.5K of Stock

D. Jonathan Merriman bought 7,000 shares of PodcastOne, Inc. at $2.21 a share, worth $15.5K in total on Sep 30, 2026. Shares held after the trade: 386,132 (+1.8%).

Value
$15.5K
Shares
7,000
Price
$2.21
Holding change
+1.8%
Trade date
Sep 30, 2026
5:29 PM ET Form 4
Insider Buying CI&T Inc CINT

CI&T CEO Cesar Nivaldo Gon Buys $11.3K of Stock

Cesar Nivaldo Gon, CEO, bought 3,835 shares of CI&T Inc at $2.95 a share, worth $11.3K in total on Sep 29, 2026. Shares held after the trade: 79,043 (+5.1%).

Value
$11.3K
Shares
3,835
Price
$2.95
Role
CEO
Holding change
+5.1%
Trade date
Sep 29, 2026
5:29 PM ET 8-K/A
M&A Deal Jasper Therapeutics, Inc. JSPR

Jasper Therapeutics M&A Deal with Kira Pharmaceuticals

Jasper Therapeutics, Inc. filed an amendment to its previous 8-K to include required financial statements and pro forma information following its completed acquisition of Kira Pharmaceuticals. The transaction was structured as a merger where Kira merged into a wholly owned subsidiary of Jasper, and the filing also references a concurrent private placement of preferred stock and a license agreement with Mirador.

Counterparty
Kira Pharmaceuticals
5:28 PM ET 8-K
Other 8-K Filing Curaleaf Holdings, Inc. CURLF

Curaleaf Holdings Other 8-K Filing

Curaleaf Holdings announced its addition to the FTSE Canada All Cap Index, effective September 18, 2026. This marks the company's second major Canadian benchmark inclusion following its 2025 addition to the S&P/TSX Composite Index, which management expects will increase liquidity and institutional investor exposure.

Counterparty
FTSE Russell
5:26 PM ET 8-K
M&A Deal Axogen, Inc. AXGN

Axogen M&A Deal with BioCircuit Technologies, Inc.

Axogen, Inc. has completed its acquisition of BioCircuit Technologies, Inc., a developer of NerveTape™, the first FDA-cleared sutureless device for peripheral nerve repair. The acquisition is expected to contribute approximately $34 million to Axogen's 2027 revenue and aligns with the company's mission to restore peripheral nerve function.

Counterparty
BioCircuit Technologies, Inc.
5:25 PM ET 8-K
Other 8-K Filing Corteva, Inc. CTVA

Corteva Other 8-K Filing

Corteva, Inc. completed the spin-off of its Seed Business into an independent publicly traded company named Vylor Inc. via a pro rata dividend in-kind to shareholders. Due to accounting rules, Vylor is treated as the accounting successor, and this filing provides the historical combined financial statements for 'New Corteva,' which now consists solely of the Crop Protection Business.

Counterparty
Vylor Inc.
5:25 PM ET 8-K
Capital Raise Pyxis Oncology, Inc. PYXS

Pyxis Oncology Capital Raise of $110M

Pyxis Oncology closed an underwritten public offering of 36,047,919 shares of common stock and pre-funded warrants, along with accompanying common warrants, at a combined price of $2.90 per share. The offering raised approximately $110 million in gross proceeds before expenses. The common warrants will only become exercisable upon stockholder approval of a charter amendment to increase the company's authorized share count.

Value
$110M
Counterparty
Leerink Partners LLC, Guggenheim Securities, LLC and Wells Fargo Securities, LLC
5:24 PM ET 8-K
Shareholder Meeting Aethlon Medical Inc AEMD

Aethlon Medical Shareholder Meeting

Aethlon Medical held its Annual Meeting of Stockholders on October 1, 2026, where shareholders elected five directors and ratified Haskell & White LLP as the independent auditor. Stockholders also approved an amendment to the 2020 Equity Incentive Plan to increase the authorized share pool by 100,000 shares and approved the potential issuance of shares related to warrants from a July 2026 offering.

5:23 PM ET 8-K
Loan & Debt Bain Capital Private Credit

Bain Capital Private Credit $350M Debt Financing

Bain Capital Private Credit priced a private placement of $350 million in 7.600% senior notes due 2031. The company intends to use the proceeds for general corporate purposes, including the repayment of existing indebtedness under its revolving credit facilities and making new portfolio investments.

Value
$350M
Term
5 years
5:23 PM ET 8-K
Loan & Debt Workday, Inc. WDAY

Workday $1.5B Debt Financing with Wells Fargo Bank, National Association

Workday, Inc. entered into a new $1.5 billion revolving credit agreement with a syndicate of lenders led by Wells Fargo, replacing its previous $1.0 billion facility. The new facility has a maturity date of October 1, 2031, and provides the company with increased liquidity for general corporate purposes.

Value
$1.5B
Counterparty
Wells Fargo Bank, National Association
Term
5 years
5:22 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $1.06M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 1,920 shares of United Therapeutics Corp at $547.29 to $554.70 a share (average $550.22) in 8 transactions, worth $1.06M in total on Sep 30, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$1.06M
Shares
1,920
Average price
$550.22
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Sep 30, 2026
5:21 PM ET 8-K
Capital Raise CNL Strategic Residential Credit, Inc.

CNL Strategic Residential Credit Capital Raise of $6.73M

CNL Strategic Residential Credit, Inc. raised approximately $6.73 million in a private offering during September 2026. The company issued 273,277 shares of Class FA common stock and 4,008 shares of Class E common stock under Rule 506(c) of Regulation D. No selling commissions or managing dealer fees were paid in connection with these specific sales.

Value
$6.73M
5:21 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $3.93M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 7,580 shares of United Therapeutics Corp at $476.14 to $546.23 a share (average $517.97) in 24 transactions, worth $3.93M in total on Sep 30, 2026. Shares held after the trade: 331,103 (-0.0%).

Value
$3.93M
Shares
7,580
Average price
$517.97
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Sep 30, 2026
5:20 PM ET 8-K
M&A Deal Powerus Corp PUSA

Aureus Greenway Holdings M&A Deal with Autonomous Power Corporation

Aureus Greenway Holdings Inc. (AGH) completed its merger with Autonomous Power Corporation (Legacy Powerus), with the combined entity renamed Powerus Corporation. In connection with the closing, the company issued approximately 134.6 million shares of common stock to Legacy Powerus stockholders, who now hold approximately 93% of the voting power. The combined company continues to trade on the Nasdaq Capital Market under the ticker PUSA.

Counterparty
Autonomous Power Corporation (Legacy Powerus)
5:20 PM ET Form 4
Insider Selling Kymera Therapeutics, Inc. KYMR

Kymera Therapeutics CEO Nello Mainolfi Sells $3.41M of Stock

Nello Mainolfi, CEO, sold 30,000 shares of Kymera Therapeutics, Inc. at $111.44 to $116.12 a share (average $113.80) in 6 transactions, worth $3.41M in total on Oct 1, 2026. Shares held after the trade: 666,568 (-0.0%).

Value
$3.41M
Shares
30,000
Average price
$113.80
Role
CEO
Holding change
-0.0%
Trade date
Oct 1, 2026
5:19 PM ET 8-K
M&A Deal Synaptics Inc SYNA

Synaptics Signs $5.7B M&A Deal with onsemi

Synaptics and onsemi have entered into an amended and restated merger agreement where onsemi will acquire Synaptics for $123 per share in cash, valuing the deal at approximately $5.7 billion. The revised agreement follows an unsolicited competing proposal from a third party and shifts the deal structure from the original June 2026 agreement to an all-cash transaction. The deal is expected to close by mid-2027 and is projected to be immediately accretive to onsemi's non-GAAP EPS.

Value
$5.7B
Counterparty
onsemi
5:19 PM ET 8-K
M&A Deal Endra Life Sciences Inc. NDRA

Endra Life Sciences M&A Deal with ASP Isotopes Inc.

ENDRA Life Sciences entered into a first amendment to its previously announced merger agreement with ASP Isotopes Inc. and Noble Africa LLC. The amendment modifies the minimum cash closing condition to approximately $3.8 million, removes classified board requirements, and increases the borrowing capacity of the target's subsidiary, Renergen, up to $200 million.

Counterparty
ASP Isotopes Inc.
5:17 PM ET Form 4
Insider Buying CNL Strategic Residential Credit, Inc.

CNL Strategic Residential Credit Insider James M. Seneff Jr. Buys $5M of Stock

James M. Seneff Jr. bought 206,101 shares of CNL Strategic Residential Credit, Inc. at $24.26 a share, worth $5M in total on Sep 30, 2026. Shares held after the trade: 306,101 (+206.1%).

Value
$5M
Shares
206,100
Price
$24.26
Holding change
+206.1%
Trade date
Sep 30, 2026
5:17 PM ET 8-K
Stock Buyback Highlands REIT, Inc.

Highlands REIT Announces $27.1M Stock Buyback

Highlands REIT, Inc. announced the final results of its self-tender offer, purchasing 135,380,970.82434 shares of its common stock at $0.20 per share. The company increased the number of shares accepted for purchase to accommodate the oversubscription, resulting in an aggregate cost of approximately $27.1 million. The repurchased shares represent approximately 18.7% of the company's outstanding common stock as of the commencement of the offer.

Value
$27.1M
5:16 PM ET Form 4
Insider Buying Vivos Inc RDGL

Vivos CEO Michael K. Korenko Buys $99.6K of Stock

Michael K. Korenko, CEO, bought 200,000 shares of Vivos Inc at $0.498 a share, worth $99.6K in total on Sep 30, 2026. Shares held after the trade: 11,635,090 (+1.7%).

Value
$99.6K
Shares
200,000
Price
$0.4980
Role
CEO
Holding change
+1.7%
Trade date
Sep 30, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.